Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 11:57 PM
Study NCT ID:
NCT00136994
Status:
COMPLETED
Last Update Posted:
2021-02-21
First Post:
2005-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-25
First Submit QC Date:
None
Study First Post Date:
2005-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-18
Last Update Post Date:
2021-02-21
Last Update Post Date Type:
ACTUAL